Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2015

01-01-2015 | Epidemiology

Pregnancy-associated breast cancer in women from Shanghai: risk and prognosis

Authors: Kathrin Strasser-Weippl, Ritesh Ramchandani, Lei Fan, Junjie Li, Marc Hurlbert, Dianne Finkelstein, Zhi-Ming Shao, Paul E. Goss

Published in: Breast Cancer Research and Treatment | Issue 1/2015

Login to get access

Abstract

Breast cancer (BC) has been associated with pregnancy if diagnosed within 5–10 years after delivery (pregnancy-associated BC, PABC). PABC carries a poor prognosis compared to sporadic BC in Western populations. Data are limited regarding PABC in Asian populations, where longer periods of breastfeeding, higher birth rates and a lower median age of BC at diagnosis have been noted, all of which are known to influence prognosis. We used two datasets of women treated for early BC in Shanghai 1990–2012 (n = 10,161 and n = 7,411). For the analysis of BC risk after pregnancy we compared the distribution of pregnancy in our dataset to that in Shanghai using age-specific fertility rates. For disease-free survival (DFS) evaluation, we restricted our data to women ≤45 years. Women <30 years had a significantly elevated BC risk within 5 years of completing a pregnancy compared to women who had not been pregnant in the previous 5 years. In women aged 20–24 the relative risk (RR) was 3.33 (P = 0.012), and for women aged 25–29 the RR was 1.76 (P = 0.0074). For women >30, the RR was decreased. Patients with PABC had a higher risk of recurrence or death (hazard ratio (HR) for DFS 1.72, P = 0.019) compared to women with non-PABC by univariable analysis. Age was eliminated from the multivariable model by backward selection, resulting in tumor stage (3 versus 1, HR 3.08, P < .001) and recent pregnancy (HR 1.62, P < 0.05) as significant independent prognosticators. Having had a full-term pregnancy in the previous 5 years was associated with a 62 % increased risk of recurrence. We show that recent full-term pregnancy significantly elevates BC risk in women <30 in Shanghai, and that women diagnosed with PABC have a particularly adverse prognosis. Health care providers and women in Asian populations should be made aware of these results.
Literature
1.
go back to reference Bruzzi P, Negri E, La Vecchia C, Decarli A, Palli D, Parazzini F (1988) Del Turco MR: short term increase in risk of breast cancer after full term pregnancy. BMJ 297:1096–1098PubMedCentralPubMedCrossRef Bruzzi P, Negri E, La Vecchia C, Decarli A, Palli D, Parazzini F (1988) Del Turco MR: short term increase in risk of breast cancer after full term pregnancy. BMJ 297:1096–1098PubMedCentralPubMedCrossRef
2.
go back to reference Layde PM, Webster LA, Baughman AL, Wingo PA, Rubin GL, Ory HW (1989) The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. Cancer and Steroid Hormone Study Group. J Clin Epidemiol 42:963–973PubMedCrossRef Layde PM, Webster LA, Baughman AL, Wingo PA, Rubin GL, Ory HW (1989) The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. Cancer and Steroid Hormone Study Group. J Clin Epidemiol 42:963–973PubMedCrossRef
3.
go back to reference Albrektsen G, Heuch I, Hansen S, Kvale G (2005) Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. Br J Cancer 92:167–175PubMedCentralPubMedCrossRef Albrektsen G, Heuch I, Hansen S, Kvale G (2005) Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. Br J Cancer 92:167–175PubMedCentralPubMedCrossRef
4.
go back to reference Kobayashi S, Sugiura H, Ando Y, Shiraki N, Yanagi T, Yamashita H, Toyama T (2012) Reproductive history and breast cancer risk. Breast Cancer 19:302–308PubMedCentralPubMedCrossRef Kobayashi S, Sugiura H, Ando Y, Shiraki N, Yanagi T, Yamashita H, Toyama T (2012) Reproductive history and breast cancer risk. Breast Cancer 19:302–308PubMedCentralPubMedCrossRef
5.
go back to reference Callihan EB, Gao D, Jindal S, Lyons TR, Manthey E, Edgerton S, Urquhart A, Schedin P, Borges VF (2013) Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer. Breast Cancer Res Treat 138:549–559PubMedCentralPubMedCrossRef Callihan EB, Gao D, Jindal S, Lyons TR, Manthey E, Edgerton S, Urquhart A, Schedin P, Borges VF (2013) Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer. Breast Cancer Res Treat 138:549–559PubMedCentralPubMedCrossRef
6.
go back to reference Whiteman MK, Hillis SD, Curtis KM, McDonald JA, Wingo PA, Marchbanks PA (2004) Reproductive history and mortality after breast cancer diagnosis. Obstet Gynecol 104:146–154PubMedCrossRef Whiteman MK, Hillis SD, Curtis KM, McDonald JA, Wingo PA, Marchbanks PA (2004) Reproductive history and mortality after breast cancer diagnosis. Obstet Gynecol 104:146–154PubMedCrossRef
7.
go back to reference Phillips K-A, Milne RL, Friedlander ML, Jenkins MA, McCredie MR, Giles GG, Hopper JL (2004) Prognosis of premenopausal breast cancer and childbirth prior to diagnosis. J Clin Oncol 22:699–705PubMedCrossRef Phillips K-A, Milne RL, Friedlander ML, Jenkins MA, McCredie MR, Giles GG, Hopper JL (2004) Prognosis of premenopausal breast cancer and childbirth prior to diagnosis. J Clin Oncol 22:699–705PubMedCrossRef
8.
go back to reference Olson SH, Zauber AG, Tang J, Harlap S (1998) Relation of time since last birth and parity to survival of young women with breast cancer. Epidemiology 9:669–671PubMedCrossRef Olson SH, Zauber AG, Tang J, Harlap S (1998) Relation of time since last birth and parity to survival of young women with breast cancer. Epidemiology 9:669–671PubMedCrossRef
9.
go back to reference Ewertz M, Duffy SW, Adami HO, Kvale G, Lund E, Meirik O, Mellemgaard A, Soini I, Tulinius H (1990) Age at first birth, parity and risk of breast cancer: a meta-analysis of eight studies from the Nordic countries. Int J Cancer 46:597–603PubMedCrossRef Ewertz M, Duffy SW, Adami HO, Kvale G, Lund E, Meirik O, Mellemgaard A, Soini I, Tulinius H (1990) Age at first birth, parity and risk of breast cancer: a meta-analysis of eight studies from the Nordic countries. Int J Cancer 46:597–603PubMedCrossRef
10.
go back to reference Lambe M, Hsieh C, Trichopoulos D, Ekbom A, Pavia M, Adami HO (1994) Transient increase in the risk of breast cancer after giving birth. N Engl J Med 331:5–9PubMedCrossRef Lambe M, Hsieh C, Trichopoulos D, Ekbom A, Pavia M, Adami HO (1994) Transient increase in the risk of breast cancer after giving birth. N Engl J Med 331:5–9PubMedCrossRef
11.
go back to reference Daling JR, Malone KE, Doody DR, Anderson BO, Porter PL (2002) The relation of reproductive factors to mortality from breast cancer. Cancer Epidemiol Biomark Prev 11:235–241 Daling JR, Malone KE, Doody DR, Anderson BO, Porter PL (2002) The relation of reproductive factors to mortality from breast cancer. Cancer Epidemiol Biomark Prev 11:235–241
12.
go back to reference Li CI, Malone KE, Daling JR, Potter JD, Bernstein L, Marchbanks PA, Strom BL, Simon MS, Press MF, Ursin G et al (2008) Timing of menarche and first full-term birth in relation to breast cancer risk. Am J Epidemiol 167:230–239PubMedCentralPubMedCrossRef Li CI, Malone KE, Daling JR, Potter JD, Bernstein L, Marchbanks PA, Strom BL, Simon MS, Press MF, Ursin G et al (2008) Timing of menarche and first full-term birth in relation to breast cancer risk. Am J Epidemiol 167:230–239PubMedCentralPubMedCrossRef
13.
go back to reference Gaudet MM, Press MF, Haile RW, Lynch CF, Glaser SL, Schildkraut J, Thompson MD, Bernstein JL, Gammon MD (2011) Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger. Breast Cancer Res Treat 130:587–597PubMedCentralPubMedCrossRef Gaudet MM, Press MF, Haile RW, Lynch CF, Glaser SL, Schildkraut J, Thompson MD, Bernstein JL, Gammon MD (2011) Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger. Breast Cancer Res Treat 130:587–597PubMedCentralPubMedCrossRef
15.
go back to reference Zheng T, Holford TR, Mayne ST, Owens PH, Zhang Y, Zhang B, Boyle P, Zahm SH (2001) Lactation and breast cancer risk: a case-control study in Connecticut. Br J Cancer 84:1472–1476PubMedCentralPubMedCrossRef Zheng T, Holford TR, Mayne ST, Owens PH, Zhang Y, Zhang B, Boyle P, Zahm SH (2001) Lactation and breast cancer risk: a case-control study in Connecticut. Br J Cancer 84:1472–1476PubMedCentralPubMedCrossRef
16.
go back to reference Lipworth L, Bailey LR, Trichopoulos D (2000) History of breast-feeding in relation to breast cancer risk: a review of the epidemiologic literature. J Natl Cancer Inst 92:302–312PubMedCrossRef Lipworth L, Bailey LR, Trichopoulos D (2000) History of breast-feeding in relation to breast cancer risk: a review of the epidemiologic literature. J Natl Cancer Inst 92:302–312PubMedCrossRef
17.
go back to reference Zhang Q, Liu LY, Wang F, Mu K, Yu ZG (2012) The changes in female physical and childbearing characteristics in China and potential association with risk of breast cancer. BMC Public Health 12:368PubMedCentralPubMedCrossRef Zhang Q, Liu LY, Wang F, Mu K, Yu ZG (2012) The changes in female physical and childbearing characteristics in China and potential association with risk of breast cancer. BMC Public Health 12:368PubMedCentralPubMedCrossRef
18.
go back to reference Lai JL, Zandecki M, Mary JY, Bernardi F, Izydorczyk V, Flactif M, Morel P, Jouet JP, Bauters F, Facon T (1995) Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood 85:2490–2497PubMed Lai JL, Zandecki M, Mary JY, Bernardi F, Izydorczyk V, Flactif M, Morel P, Jouet JP, Bauters F, Facon T (1995) Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood 85:2490–2497PubMed
19.
go back to reference Fan L, Yu KD, Liu GY, Wu J, Lu JS, Shen KW, Shen ZZ, Shao ZM (2009) Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China. Breast Cancer Res Treat 117:409–416PubMedCrossRef Fan L, Yu KD, Liu GY, Wu J, Lu JS, Shen KW, Shen ZZ, Shao ZM (2009) Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China. Breast Cancer Res Treat 117:409–416PubMedCrossRef
20.
go back to reference Li J, Zhang BN, Fan JH, Pang Y, Zhang P, Wang SL, Zheng S, Zhang B, Yang HJ, Xie XM et al (2011) A nation-wide multicenter 10-year (1999–2008) retrospective clinical epidemiological study of female breast cancer in China. BMC Cancer 11:364PubMedCentralPubMedCrossRef Li J, Zhang BN, Fan JH, Pang Y, Zhang P, Wang SL, Zheng S, Zhang B, Yang HJ, Xie XM et al (2011) A nation-wide multicenter 10-year (1999–2008) retrospective clinical epidemiological study of female breast cancer in China. BMC Cancer 11:364PubMedCentralPubMedCrossRef
21.
go back to reference Liu Q, Wuu J, Lambe M, Hsieh S-F, Ekbom A, Hsieh C-C (2002) Transient increase in breast cancer risk after giving birth: postpartum period with the highest risk (Sweden). Cancer Causes Control 13:299–305PubMedCrossRef Liu Q, Wuu J, Lambe M, Hsieh S-F, Ekbom A, Hsieh C-C (2002) Transient increase in breast cancer risk after giving birth: postpartum period with the highest risk (Sweden). Cancer Causes Control 13:299–305PubMedCrossRef
22.
go back to reference Lee SY, Kim MT, Kim SW, Song MS, Yoon SJ (2003) Effect of lifetime lactation on breast cancer risk: a Korean women’s cohort study. Int J Cancer 105:390–393PubMedCrossRef Lee SY, Kim MT, Kim SW, Song MS, Yoon SJ (2003) Effect of lifetime lactation on breast cancer risk: a Korean women’s cohort study. Int J Cancer 105:390–393PubMedCrossRef
23.
go back to reference Potter JD, Cerhan JR, Sellers TA, McGovern PG, Drinkard C, Kushi LR, Folsom AR (1995) Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women’s Health Study: How many kinds of breast cancer are there? Cancer Epidemiol Biomark Prev 4:319–326 Potter JD, Cerhan JR, Sellers TA, McGovern PG, Drinkard C, Kushi LR, Folsom AR (1995) Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women’s Health Study: How many kinds of breast cancer are there? Cancer Epidemiol Biomark Prev 4:319–326
24.
go back to reference Ma H, Bernstein L, Pike MC, Ursin G (2006) Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res 8:R43PubMedCentralPubMedCrossRef Ma H, Bernstein L, Pike MC, Ursin G (2006) Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res 8:R43PubMedCentralPubMedCrossRef
25.
go back to reference Marchbanks PA, McDonald JA, Wilson HG, Burnett NM, Daling JR, Bernstein L, Malone KE, Strom BL, Norman SA, Weiss LK et al (2002) The NICHD women’s contraceptive and reproductive experiences study: methods and operational results. Ann Epidemiol 12:213–221PubMedCrossRef Marchbanks PA, McDonald JA, Wilson HG, Burnett NM, Daling JR, Bernstein L, Malone KE, Strom BL, Norman SA, Weiss LK et al (2002) The NICHD women’s contraceptive and reproductive experiences study: methods and operational results. Ann Epidemiol 12:213–221PubMedCrossRef
26.
go back to reference Colditz G, Rosner B, Chen W, Holmes M, Hankinson S (2004) Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst 96:218–228PubMedCrossRef Colditz G, Rosner B, Chen W, Holmes M, Hankinson S (2004) Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst 96:218–228PubMedCrossRef
27.
go back to reference Britton JA, Gammon MD, Schoenberg JB, Stanford JL, Coates RJ, Swanson CA, Potischman N, Malone KE, Brogan DJ, Daling JR, Brinton LA (2002) Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20–44 years of age. Am J Epidemiol 156:507–516PubMedCrossRef Britton JA, Gammon MD, Schoenberg JB, Stanford JL, Coates RJ, Swanson CA, Potischman N, Malone KE, Brogan DJ, Daling JR, Brinton LA (2002) Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20–44 years of age. Am J Epidemiol 156:507–516PubMedCrossRef
28.
go back to reference Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG (2000) Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol 151:703–714PubMedCrossRef Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG (2000) Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol 151:703–714PubMedCrossRef
29.
go back to reference Yoo KY, Tajima K, Miura S, Takeuchi T, Hirose K, Risch H, Dubrow R (1997) Breast cancer risk factors according to combined estrogen and progesterone receptor status: a case-control analysis. Am J Epidemiol 146:307–314PubMedCrossRef Yoo KY, Tajima K, Miura S, Takeuchi T, Hirose K, Risch H, Dubrow R (1997) Breast cancer risk factors according to combined estrogen and progesterone receptor status: a case-control analysis. Am J Epidemiol 146:307–314PubMedCrossRef
30.
go back to reference McCredie MR, Dite GS, Southey MC, Venter DJ, Giles GG, Hopper JL (2003) Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status. Br J Cancer 89:1661–1663PubMedCentralPubMedCrossRef McCredie MR, Dite GS, Southey MC, Venter DJ, Giles GG, Hopper JL (2003) Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status. Br J Cancer 89:1661–1663PubMedCentralPubMedCrossRef
31.
go back to reference Cotterchio M, Kreiger N, Theis B, Sloan M, Bahl S (2003) Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup. Cancer Epidemiol Biomark Prev 12:1053–1060 Cotterchio M, Kreiger N, Theis B, Sloan M, Bahl S (2003) Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup. Cancer Epidemiol Biomark Prev 12:1053–1060
32.
go back to reference Rusiecki JA, Holford TR, Zahm SH, Zheng T (2005) Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status. Cancer Detect Prev 29:419–426PubMedCrossRef Rusiecki JA, Holford TR, Zahm SH, Zheng T (2005) Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status. Cancer Detect Prev 29:419–426PubMedCrossRef
33.
go back to reference Ursin G, Bernstein L, Lord SJ, Karim R, Deapen D, Press MF, Daling JR, Norman SA, Liff JM, Marchbanks PA (2005) Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer 93:364–371PubMedCentralPubMedCrossRef Ursin G, Bernstein L, Lord SJ, Karim R, Deapen D, Press MF, Daling JR, Norman SA, Liff JM, Marchbanks PA (2005) Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer 93:364–371PubMedCentralPubMedCrossRef
34.
go back to reference Bemis LT, Schedin P (2000) Reproductive state of rat mammary gland stroma modulates human breast cancer cell migration and invasion. Cancer Res 60:3414–3418PubMed Bemis LT, Schedin P (2000) Reproductive state of rat mammary gland stroma modulates human breast cancer cell migration and invasion. Cancer Res 60:3414–3418PubMed
35.
36.
37.
go back to reference Ries LAG, Eisner MP, Kosary CL (2001) SEER cancer statistics review, 1973–1998. National Cancer Institute, Bethesda Ries LAG, Eisner MP, Kosary CL (2001) SEER cancer statistics review, 1973–1998. National Cancer Institute, Bethesda
38.
go back to reference Trichopoulos D, Hsieh CC, MacMahon B, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG, Yuasa S (1983) Age at any birth and breast cancer risk. Int J Cancer 31:701–704PubMedCrossRef Trichopoulos D, Hsieh CC, MacMahon B, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG, Yuasa S (1983) Age at any birth and breast cancer risk. Int J Cancer 31:701–704PubMedCrossRef
39.
go back to reference MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG, Yuasa S (1970) Age at first birth and breast cancer risk. Bull World Health Organ 43:209–221PubMedCentralPubMed MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG, Yuasa S (1970) Age at first birth and breast cancer risk. Bull World Health Organ 43:209–221PubMedCentralPubMed
40.
go back to reference Schoenfeld D (1982) Partial residuals for the proportional hazards regression model. Biometrika 69:239–241CrossRef Schoenfeld D (1982) Partial residuals for the proportional hazards regression model. Biometrika 69:239–241CrossRef
41.
go back to reference Rubin DB (2008) Introduction. In: Rubin DB (ed) Multiple Imputation for Nonresponse in Surveys, vol 1. Wiley, Inc., New York, pp 1–26 Rubin DB (2008) Introduction. In: Rubin DB (ed) Multiple Imputation for Nonresponse in Surveys, vol 1. Wiley, Inc., New York, pp 1–26
42.
go back to reference van Buuren S, Groothuis-Oudshoorn K (2011) Mice: multivariate imputation by chained equations in R. J Stat Softw 45:1–67 van Buuren S, Groothuis-Oudshoorn K (2011) Mice: multivariate imputation by chained equations in R. J Stat Softw 45:1–67
Metadata
Title
Pregnancy-associated breast cancer in women from Shanghai: risk and prognosis
Authors
Kathrin Strasser-Weippl
Ritesh Ramchandani
Lei Fan
Junjie Li
Marc Hurlbert
Dianne Finkelstein
Zhi-Ming Shao
Paul E. Goss
Publication date
01-01-2015
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2015
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-014-3219-9

Other articles of this Issue 1/2015

Breast Cancer Research and Treatment 1/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine